Insights
Media CenterLatest Therapy Updates
- Affiliated First People’s Hospital Uses High-Intensity Focused Ultrasound Ablation for a Complex Prostate Cancer Case for the First Time
- Using oncolytic viruses to eliminate tumor cells, Shanghai’s innovative drug results appear in Nature magazine
- Sichuan Kelun Pharmaceutical Co., Ltd. announced that its subsidiary's core product sacituzumab tirumotecan (sac-TMT) has been approved by the National Medical Products Administration for the second indication (for the treatment of EGFR mutated non-small cell lung cancer).
- Academician Ma Jun’s team creates new standards for precision radiotherapy
- A “Chinese Approach” to Immunotherapy for Triple-Negative Breast Cancer
Page 11 of 12
What could this mean for your care?
A promising treatment raises a personal question: could it be an option for you? Chirona helps you explore that question with the right specialists.
Start a case reviewHow our service worksUnderstand your options
Explore the treatments relevant to your diagnosis, previous care and priorities.
Bring your case to specialists
We help organise your medical records and coordinate a professional assessment of suitability and access.
Plan the next step together
If a treatment path is appropriate, we help coordinate consultations, hospital arrangements and continuity of care.


